Skip to content

The Effects of Propofol and Cipropofol on Perioperative Neurocognitive Disorders in Elderly Patients

The Effects of Propofol and Cipropofol on Perioperative Neurocognitive Disorders in Elderly Patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117749
Enrollment
Unknown
Registered
2026-01-28
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative neurocognitive disorders

Interventions

Group C:During the surgical procedure, intravenous infusion of 0.4-2.4mg/kg/h cyclosporine and 0.3-0.5 µ g/kg/min remifentanil was administered
Group P:During the surgery, intravenous infusion of 4-6mg/kg/h propofol and 0.3-0.5 µ g/kg/min remifentanil was administered

Sponsors

Inner Mongolia Medical University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age >= 60 years old; (2) American Society of Anesthesiologists (ASA) classification II-III; (3) Patients undergoing elective laparoscopic resection of colorectal tumors under general anesthesia; (4) Voluntarily participate in this clinical trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Previous history of drug dependence, such as antipsychotic drugs, anti anxiety drugs, antidepressants, stimulants, and opioid drugs; (2) History of mental or psychological illness in the past; (3) History of neurological disorders that affect cognitive function, such as Alzheimer's disease (AD), vascular dementia, and any other form of dementia; (4) Preoperative Montreal Cognitive Assessment (MoCA) score<26 points; (5) Unable to understand the evaluation scales related to this study or uncooperative evaluators; (6) Lack of follow-up data; (7) Participated in other clinical trials within the 3 months prior to being selected for this study.

Design outcomes

Primary

MeasureTime frame
Postoperative delirium incidence rate;Incidence of delayed early postoperative neurocognitive recovery;

Secondary

MeasureTime frame
VAS score ;NRS score ;Restore quality;Preoperative and postoperative C-reactive protein/interleukin-6/procalcitonin;Cerebral oxygen saturation;Mean arterial pressure/heart rate;General situation/intraoperative situation;Postoperative adverse events;Intraoperative minimum mean arterial pressure;

Countries

China

Contacts

Public ContactSun Tao

Inner Mongolia Medical University Affiliated Hospital

1095414387@qq.com+86 191 4504 5322

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026